<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors studied the effects of <z:chebi fb="1" ids="29864">mannitol</z:chebi> on intracranial pressure (ICP) in experimental focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in a rat </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001297'>Stroke</z:hpo> was produced by occlusion of middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) </plain></SENT>
<SENT sid="2" pm="."><plain>The study revealed that <z:chebi fb="1" ids="29864">mannitol</z:chebi> decreases ICP in <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> much less then in healthy animals and also a significant rebound effect was seen, especially in the 5th and 7th day after <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion </plain></SENT>
<SENT sid="3" pm="."><plain>The authors suggest a very limited use of <z:chebi fb="1" ids="29864">mannitol</z:chebi> in clinical treatment of elevated ICP after cerebral <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
</text></document>